Overview
CEF25, Influenza Virus NP (44-52) is a specialized peptide that serves as an HLA-A*01 restricted epitope derived from the influenza virus nucleoprotein. This peptide is essential for research and diagnostic applications involving T-cell responses to influenza, allowing scientists and researchers to investigate immune responses and vaccine effectiveness. If you’re looking to enhance your studies on influenza viruses, CEF25 is a reliable choice.
Key Features
- Specificity: HLA-A*01 restricted epitope from influenza nucleoprotein.
- High-quality synthesis for reliable results in research.
- Ideal for studies related to T-cell activation and immune response.
- 1 mg vial for convenient handling in laboratory settings.
- Supports various immunological assays and experiments.
Specifications
| Product Name | CEF25, Influenza Virus NP (44-52) |
| Category | Peptides |
| Amount | 1 mg |
| Application | Research and diagnostic studies |
| Epitope | HLA-A*01 restricted |
FAQ
What is CEF25 used for?
CEF25 is primarily used in research to study immune responses, particularly T-cell recognition of influenza viruses. Researchers utilize this peptide to gain insights into vaccine development and immune profiling.
How should I store CEF25?
It is recommended to store CEF25 in a freezer at -20°C to maintain its integrity. Ensure that it is kept in a tightly sealed container to protect it from moisture and light.
Can CEF25 be used in immunological assays?
Yes, CEF25 is designed for use in various immunological assays, including those that measure T-cell activation and responses to influenza antigens. Its reliability makes it a valuable tool for researchers in the field.
If you are in need of a high-quality peptide for your influenza virus research, CEF25 is available for purchase. Explore more options in our collection of peptides and enhance your research capabilities today.




Reviews
There are no reviews yet.